A high expression of Cyclin D1 and CDK4 is frequently found in breast cancer and deregulation of this pathway contributes to uncontrolled proliferation in hormone receptor-positive breast cancer [22,23,24,25]. Here, CDK4 is linked to breast carcinoma.